v3.25.1
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 9 Months Ended
Mar. 31, 2025
USD ($)
item
shares
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2025
USD ($)
item
shares
Mar. 31, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Cash and cash equivalents $ 9,852,007   $ 9,852,007   $ 6,100,031  
Number of revenue streams | item 2   2      
Revenue recognized that was included in deferred revenue     $ 5,980,919 $ 4,610,262    
Deferred Revenue $ 10,355,768   10,355,768   9,023,848 $ 6,424,724
Accounts receivable 7,604,058   $ 7,604,058   6,879,800 $ 6,153,063
Estimated average useful life     10 years      
Foreign currency transaction gain (loss) $ 44,519 $ (22,177) $ 119,205 $ (15,059)    
Business Combination, Contingent Consideration, Liability, Measurement Input 0.10   0.10      
Business Combination, Contingent Consideration, Liability, Measurement Input [Extensible Enumeration] us-gaap:MeasurementInputDiscountRateMember   us-gaap:MeasurementInputDiscountRateMember      
Employee Stock Option [Member]            
Antidilutive securities, number | shares 770,287 8,000 2,791,702 2,641,492    
Restricted Stock [Member]            
Antidilutive securities, number | shares 2,139,100 2,329,900 2,221,495 2,715,191    
Maximum | Scite | Developed Technology and Customer Relationships            
Estimated average useful life     10 years      
Minimum | Scite | Developed Technology and Customer Relationships            
Estimated average useful life     3 years      
Europe financial institutions            
Cash and cash equivalents $ 612,725   $ 612,725   $ 630,680